The study began with sixty-six RA patients, between the ages of 20 and 69. Thirty-eight patients followed the vegan diet, and 28 followed the well-balanced non-vegan diet. Blood samples were collected at the start of the study, and at three, and 12 months. Patients' weight and BMI were also recorded. Eight patients in the vegan group dropped out before the end of 12 months. Patients were tested for LDL (bad cholesterol) levels, HDL (good cholesterol), and triglycerides (fats). LDL is considered to be atherogenic (atherosclerosis-inducing). Patients were also tested for the antibody IgM anti-phosphorylcholine (PC), an antibody that is protective against atherosclerosis.
Patients in the vegan group showed progress at three and 12 months. LDL levels, total cholesterol, and the ratio of LDL to HDL dropped significantly after both 3 and 12 months. HDL and triglycerides did not change. IgM anti-PC levels increased after 3 and 12 months. Results were much more modest in the non-vegan group. The typical weight in the vegan group dropped by about 4 pounds after 12 months, and BMI went from 24.1 to 22.7. Patients in the non-vegan group dropped less than one pound, and their BMI went from 23.8 to 23.4, an insignificant decrease. The overall effect of the vegan diet was a decrease in inflammatory indicators, and an increase in levels of protective markers.
Other studies have already established the benefits of a vegan diet, which include lowered blood pressure and cholesterol levels, easier weight management, and decreased inflammation. Although the non-vegan diet was nutritionally sound, and included five or more servings of fruits and vegetables, it was the non-dairy, non-gluten, vegan diet that provided the most noticeable improvement. Future research may focus on efforts to discover what is so special about a vegan diet. This study represents more evidence for the old notion that eating plants is good medicine.
Reference
Elkan, A., Sjöberg, B. Kolsrud, B., Ringertz, B., Hafström, I., Frostegård, J.
Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study
Published by Debbie Luyo
I am a writer and editor with an interest and background in science and health. View profile
- Prevent Cardiovascular Disease: Get Your High Blood Pressure Under ControlHigh blood pressure is the most common cardiovascular disease among adults. Stress has notable effects on the cardiovascular system. Research is unlocking a complex relationship between stress, high blood pressure and...
- How Rheumatoid Arthritis Affects Oral HealthPeople who suffer with Rheumatoid Arthritis (RA) live with an array of symptoms that range from mild to debilitating. The obvious effects of RA are on the joints of the the hands, wrists, knees and feet. Less well k...
- Cataflam: Agent for Rheumatoid ArthritisIf you have recently suffered from rheumatoid arthritis, and your doctor has prescribed your Cataflam (Diclofenac Potassium), or if you are simply trying to learn more about this prescription medicine, then this liter...
Feldene: Relief from the Pain of Rheumatoid ArthritisFeldene is indicated for rheumatoid arthritis and osteo-arthritis.
Harvard Study: Antioxidants Have No Clear Benefit on Cardiovascular DiseaseThere is evidence suggesting that supplementation with vitamins C and E and beta-carotene does not reduce cardiovascular events in women at high risk for cardiovascular disease...
- Living with Rheumatoid Arthritis
- Rheumatoid Arthritis
- Helping Your Child Deal with Juvenile Rheumatoid Arthritis
- Erectile Dysfunction (ED) May Be a Symptom of Cardiovascular Disease
- Enbrel: FDA Approval in the Treatment of Juvenile Rheumatoid Arthritis
- What is Juvenile Rheumatoid Arthritis (JRA)?
- Living with Rheumatoid Arthritis



